Post-translational modifications of immune checkpoints: unlocking new potentials in cancer immunotherapy

被引：0
|
作者：
Hu, Qiongjie [1 ,3 ]
Shi, Yueli [1 ,2 ]
Wang, Huang [4 ]
Bing, Liuwen [3 ]
Xu, Zhiyong [1 ,2 ]
机构：
[1] Zhejiang Univ, Sch Med, Affiliated Hosp 4, Dept Resp & Crit Care Med, Yiwu 322000, Zhejiang, Peoples R China
[2] Zhejiang Key Lab Precis Diag & Treatment Lung Canc, Yiwu 322000, Peoples R China
[3] Zhejiang Chinese Med Univ, Affiliated Hosp 3, Hangzhou 310013, Peoples R China
[4] Nanjing Med Univ, Affiliated Hosp 1, Dept Resp & Crit Care Med, Nanjing, Peoples R China
来源：
EXPERIMENTAL HEMATOLOGY & ONCOLOGY | 2025年 / 14卷 / 01期
基金：
中国国家自然科学基金;
关键词：
Cancer immunotherapy; Immune checkpoint blockade; Post-translational modifications; Ubiquitination; Phosphorylation; ANTIBODY-BASED PROTACS; CELL LUNG-CANCER; SIRP-ALPHA; TUMOR MICROENVIRONMENT; PD-L1; EXPRESSION; BREAST-CANCER; T-CELLS; COINHIBITORY PATHWAYS; REGULATES ANTITUMOR; ACQUIRED-RESISTANCE;
D O I：
10.1186/s40164-025-00627-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Immunotherapy targeting immune checkpoints has gained traction across various cancer types in clinical settings due to its notable advantages. Despite this, the overall response rates among patients remain modest, alongside issues of drug resistance and adverse effects. Hence, there is a pressing need to enhance immune checkpoint blockade (ICB) therapies. Post-translational modifications (PTMs) are crucial for protein functionality. Recent research emphasizes their pivotal role in immune checkpoint regulation, directly impacting the expression and function of these key proteins. This review delves into the influence of significant PTMs-ubiquitination, phosphorylation, and glycosylation-on immune checkpoint signaling. By targeting these modifications, novel immunotherapeutic strategies have emerged, paving the way for advancements in optimizing immune checkpoint blockade therapies in the future.
引用
收藏
页数：28
相关论文
共 50 条
  • [41] Post-translational Histone Modifications in Circulating Nucleosomes as New Biomarkers in Colorectal Cancer
    Gezer, Ugur
    Holdenrieder, Stefan
    IN VIVO, 2014, 28 (03): : 287 - 292
  • [42] Post-translational modifications in priming the plant immune system: ripe for exploitation?
    de Vega, Daniel
    Newton, Adrian C.
    Sadanandom, Ari
    FEBS LETTERS, 2018, 592 (12) : 1929 - 1936
  • [43] Unleashing the power of immune checkpoints: Post-translational modification of novel molecules and clinical applications
    Wang, Jie
    Wang, Yian
    Jiang, Xianjie
    Xu, Meifang
    Wang, Meifeng
    Wang, Rong
    Zheng, Boshu
    Chen, Mingfen
    Ke, Qi
    Long, Jun
    CANCER LETTERS, 2024, 588
  • [44] Proteomics attack on post-translational modifications
    Delcourt, Nicolas
    M S-MEDECINE SCIENCES, 2007, 23 (02): : 219 - 220
  • [45] POST-TRANSLATIONAL MODIFICATIONS OF RICE LECTIN
    STINISSEN, HM
    PEUMANS, WJ
    CARLIER, AR
    ARCHIVES INTERNATIONALES DE PHYSIOLOGIE DE BIOCHIMIE ET DE BIOPHYSIQUE, 1982, 90 (04): : B216 - B217
  • [46] Post-translational Modifications of Opioid Receptors
    Duarte, Mariana Lemos
    Devi, Lakshmi A.
    TRENDS IN NEUROSCIENCES, 2020, 43 (06) : 417 - 432
  • [47] Post-translational modifications in prion diseases
    Bizingre, Chloe
    Bianchi, Clara
    Baudry, Anne
    Alleaume-Butaux, Aurelie
    Schneider, Benoit
    Pietri, Mathea
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2024, 17
  • [48] Tubulin post-translational modifications in meiosis
    Akera, Takashi
    SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2023, 137 : 38 - 45
  • [49] Proteomic analysis of post-translational modifications
    Matthias Mann
    Ole N. Jensen
    Nature Biotechnology, 2003, 21 : 255 - 261
  • [50] Post-translational protein modifications in schizophrenia
    Toni M. Mueller
    James H. Meador-Woodruff
    npj Schizophrenia, 6
12345